First Trust Advisors LP C4 Therapeutics, Inc. Transaction History

First Trust Advisors LP

  • $95 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 08, 2022
SELL
$29.39 - $46.86 $2.56 Million - $4.07 Million
-86,952 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$35.91 - $50.5 $2.32 Million - $3.27 Million
64,688 Added 290.55%
86,952 $3.89 Million
Q2 2021

Aug 16, 2021
BUY
$30.39 - $42.18 $676,602 - $939,095
22,264 New
22,264 $842,000

Others Institutions Holding CCCC

# of Institutions
122
Shares Held
53.8M
Call Options Held
331K
Put Options Held
145K
View Full List

About C4 Therapeutics, Inc.

CCCC Quotes by TradingView
  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $293M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email